Stay updated on Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice states the study is no longer looking for participants. The Intervention/Treatment heading formatting was adjusted and the revision label updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-15T06:58:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.5.4 to v3.5.5, signaling a newer release version of the page. This update does not modify the study details or visible content.
    Difference
    0.0%
    Check dated 2026-06-08T03:56:21.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, representing a minor update to the page's revision label. It does not modify the study content or eligibility details on the entry.
    Difference
    0.0%
    Check dated 2026-05-17T09:24:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical study details.
    Difference
    0.0%
    Check dated 2026-04-25T18:45:06.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the site.
    Difference
    0.0%
    Check dated 2026-04-18T13:41:24.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.3 to v3.5.0. No study content or eligibility details appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-21T00:52:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.